Operationalizing diagnostic criteria for Alzheimer's disease and other age‐related cognitive impairment—Part 2

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Alzheimer's & Dementia

• Publication date

  2011-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jalz.2010.12.002PMID 21255742PMCID PMC3039838
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diagnostic and Statistical Manual of Mental Disorders

  2013cited by this paper
• National estimates of the prevalence of Alzheimer's disease in the United States

  2011cited by this paper
• [Clinical Dementia Rating (CDR)].

  2011cited by this paper
• Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

  2011influential reference
• Sources of variability in estimates of the prevalence of Alzheimer's disease in the United States

  2011cited by this paper
• Operationalizing diagnostic criteria for Alzheimer's disease and other age‐related cognitive impairment—Part 1

  2011cited by this paper
• COGNITIVE DECLINE IN INCIDENT ALZHEIMER DISEASE IN A COMMUNITY POPULATION

  2010cited by this paper
• Cognitive decline in incident Alzheimer disease in a community population

  2010cited by this paper
• Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.

  2010cited by this paper
• Prevalence of mild cognitive impairment is higher in men

  2010influential reference
• Dementia incidence continues to increase with age in the oldest old: The 90+ study

  2010cited by this paper
• Alzheimer's disease: progress in prediction

  2010cited by this paper
• Enrichment through biomarkers in clinical trials of Alzheimer's drugs in patients with mild cognitive impairment.

  2010cited by this paper
• Alzheimer's Disease Neuroimaging Initiative (ADNI)

  2010cited by this paper
• The neuropathology of probable Alzheimer disease and mild cognitive impairment

  2009cited by this paper
• Age, neuropathology, and dementia.

  2009cited by this paper
• Faculty Opinions recommendation of Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study.

  2009cited by this paper
• APOE ε2 is associated with intact cognition but increased Alzheimer pathology in the oldest old

  2009cited by this paper
• The Neuropathology of Older Persons with and Without Dementia from Community versus Clinic Cohorts

  2009cited by this paper
• Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

  2009cited by this paper
• Relationships between biomarkers in aging and dementia

  2009cited by this paper
• Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.

  2009cited by this paper
• Conversion of amyloid positive and negative MCI to AD over 3 years

  2009cited by this paper
• Mild cognitive impairment: ten years later.

  2009cited by this paper
• Two‐Year Progression from Mild Cognitive Impairment to Dementia: To What Extent Do Different Definitions Agree?

  2008cited by this paper
• The Mayo Clinic Study of Aging: Design and Sampling, Participation, Baseline Measures and Sample Characteristics

  2008cited by this paper
• Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

  2008cited by this paper
• Characterization of Japanese-American men with a single neocortical AD lesion type.

  2008cited by this paper
• Prevalence of dementia after age 90

  2008cited by this paper
• The Medical Research Council Cognitive Function and Ageing Study

  2007cited by this paper
• Lifetime risk of stroke and dementia: current concepts, and estimates from the Framingham Study.

  2007cited by this paper
• Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia.

  2006cited by this paper
• Duke Twins Study of Memory in Aging in the NAS-NRC Twin Registry

  2006cited by this paper
• The lifetime risk of stroke: estimates from the Framingham Study.

  2006cited by this paper
• Comparison of clinical and neuropathologic diagnoses of Alzheimer's disease in 3 epidemiologic samples

  2006cited by this paper
• Diagnosis of Alzheimer's disease: Two decades of progress

  2005cited by this paper
• Diagnosis of Alzheimer's disease: Two-decades of progress

  2005cited by this paper
• The Aging, Demographics, and Memory Study: Study Design and Methods

  2005cited by this paper
• Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B

  2004cited by this paper
• Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment

  2004cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)

  2003cited by this paper
• Neuropathology of Cognitively Normal Elderly

  2003cited by this paper
• Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status.

  2003influential reference
• Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

  2002cited by this paper
• Causes and consequences of comorbidity: a review.

  2001cited by this paper
• Documented head injury in early adulthood and risk of Alzheimer’s disease and other dementias

  2000cited by this paper
• Comorbidity of five chronic health conditions in elderly community residents: determinants and impact on mortality.

  2000cited by this paper
• The relative frequency of "dementia of unknown etiology" increases with age and is nearly 50% in nonagenarians.

  2000cited by this paper
• Age-specific incidence rates of Alzheimer’s disease

  2000influential reference
• The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort.

  2000cited by this paper
• Computing estimates of incidence, including lifetime risk: Alzheimer's disease in the Framingham Study. The Practical Incidence Estimators (PIE) macro.

  2000cited by this paper
• APOE-ε4 count predicts age when prevalence of AD increases, then declines

  1999cited by this paper
• APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study.

  1999cited by this paper
• Mild Cognitive Impairment Clinical Characterization and Outcome

  1999cited by this paper
• Report of the second dementia with Lewy body international workshop

  1999cited by this paper
• Alzheimer neuropathologic alterations in aged cognitively normal subjects.

  1999cited by this paper
• A clinicopathological comparison of community-based and clinic-based cohorts of patients with dementia.

  1999cited by this paper
• Clinico‐Neuropathological Correlation of Alzheimer's Disease in a Community‐Based Case Series

  1999cited by this paper
• Change in cognitive function in older persons from a community population: relation to age and Alzheimer disease.

  1999cited by this paper
• Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

  1998cited by this paper
• Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease.

  1998cited by this paper
• A study of the Lund‐Manchester research criteria for frontotemporal dementia

  1997cited by this paper
• Lifetime risk of dementia and Alzheimer's disease

  1997cited by this paper
• The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology Confirmation of the Clinical Diagnosis of Alzheimer's Disease

  1995cited by this paper
• Age-specific incidence of Alzheimer's disease in a community population.

  1995influential reference
• Alzheimer's disease in the National Academy of Sciences-National Research Council Registry of Aging Twin Veterans. III. Detection of cases, longitudinal results, and observations on twin concordance.

  1995cited by this paper
• Vascular dementia

  1993cited by this paper
• Incidence of dementia and probable Alzheimer's disease in a general population

  1993influential reference
• Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study

  1992cited by this paper
• Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers

  1992cited by this paper
• The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

  1991cited by this paper
• Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer's disease.

  1991cited by this paper
• Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported.

  1989cited by this paper
• Prevalence of medically diagnosed dementia in a defined United States population

  1989cited by this paper
• Development of dementing illnesses in an 80‐year‐old volunteer cohort

  1989cited by this paper
• Clinical Dementia Rating (CDR).

  1988cited by this paper
• Clinical Trials: Design, Conduct, and Analysis

  1987cited by this paper
• Neuropsychological test performance in Framingham: a descriptive study.

  1987cited by this paper
• General view on the criteria utilized for psychiatric diagnoses feighner research diagnostic criteria diagnostic and statistical manual of mental disorders dsm iii

  1986cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984influential reference
• Clinical Dementia Rating

  1984cited by this paper
• Diagnostic criteria for primary neuronal degeneration of the Alzheimer's type.

  1980cited by this paper
• The Framingham Offspring Study. Design and preliminary data.

  1975cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper
• The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects

  1968influential reference
• The Framingham Study An Epidemiological Approach to Coronary Heart Disease

  1966cited by this paper

• Temporal Trends in Incidence of Dementia in a Birth Cohorts Analysis of the Framingham Heart Study

  2026cites this paper
• Genome‐wide pleiotropy analysis of longitudinal blood pressure and harmonized cognitive performance measures

  2025cites this paper
• Multimarker Cerebral Small Vessel Disease Score and Risk of Incident Dementia in the Framingham Heart Study

  2025cites this paper
• Ultra-processed food consumption and risk of dementia and Alzheimer's disease: The Framingham Heart Study

  2025cites this paper
• Vascular Contributions to Cognitive Impairment and Dementia in the United States: Prevalence and Incidence: A Scientific Statement From the American Heart Association.

  2025cites this paper
• Single- versus two-test criteria for cognitive impairment: associations with CSF and imaging markers in former American football players

  2025influential citation
• Impaired kidney function, cerebral small vessel disease and cognitive disorders: the Framingham Heart Study

  2024cites this paper
• Digital neuropsychological measures by defense automated neurocognitive assessment: reference values and clinical correlates

  2024cites this paper
• Associations Between Glucose Metabolism Measures and Amyloid-β and Tau Load on PET 14 Years Later: Findings From the Framingham Heart Study

  2024cites this paper
• Resting heart rate (variability) and cognition relationships reveal cognitively healthy individuals with pathological amyloid/tau ratio

  2023cites this paper
• A genome-wide search for pleiotropy in more than 100,000 harmonized longitudinal cognitive domain scores

  2023cites this paper
• Diet, pace of biological aging, and risk of dementia in the Framingham Heart Study

  2023cites this paper
• Ceiling effects and differential measurement precision across calibrated cognitive scores in the Framingham Study.

  2023cites this paper
• Inequality in housing transitions during cognitive decline

  2023cites this paper
• Patterns of Aging Changes in Bodyweight May Predict Alzheimer’s Disease

  2023cites this paper
• Classification of Alzheimer’s Progression Using fMRI Data

  2023cites this paper
• Association of Pace of Aging Measured by Blood-Based DNA Methylation With Age-Related Cognitive Impairment and Dementia

  2022cites this paper
• MRI-Visible Perivascular Spaces and Risk of Incident Dementia

  2022influential citation
• Association between inflammatory biomarkers and cognitive aging

  2022cites this paper
• Association of Aortic Stiffness and Pressure Pulsatility With Global Amyloid-β and Regional Tau Burden Among Framingham Heart Study Participants Without Dementia.

  2022cites this paper
• Platelet Function Is Associated With Dementia Risk in the Framingham Heart Study

  2022cites this paper
• A predictive model for the risk of cognitive impairment in community middle-aged and older adults.

  2022cites this paper
• Association Between Elevated Depressive Symptoms and Cognitive Function Moderated by APOE4 Status: Framingham Offspring Study

  2021cites this paper
• The Neutrophil to Lymphocyte Ratio Is Associated With the Risk of Subsequent Dementia in the Framingham Heart Study

  2021cites this paper
• Long work hours, prolonged daytime naps, and decreased cognitive performance in older adults

  2020cites this paper
• Development and Validation of a Nomogram for Predicting the 6-Year Risk of Cognitive Impairment Among Chinese Older Adults.

  2020cites this paper
• Linguistic markers predict onset of Alzheimer's disease

  2020influential citation
• Development and validation of a nomogram for predicting the six-year risk of cognitive impairment among Chinese older adults

  2020cites this paper
• Cardiovascular health, genetic risk, and risk of dementia in the Framingham Heart Study

  2020cites this paper
• Strategies to solve the reverse inference fallacy in future MRI studies of schizophrenia: a review

  2020cites this paper
• Using data science to diagnose and characterize heterogeneity of Alzheimer's disease

  2019cites this paper
• Alzheimer's disease progression and risk factors: A standardized comparison between six large data sets

  2019cites this paper
• A multi-state model based reanalysis of the Framingham Heart Study: Is dementia incidence really declining?

  2019cites this paper
• Study cognitive function in the elderly by testing rapid assessment of cognitive functions (ERFC)

  2019cites this paper
• Evaluation of Medicare Claims Data as a Tool to Identify Dementia

  2019cites this paper
• White matter hypointensities and hyperintensities have equivalent correlations with age and CSF β‐amyloid in the nondemented elderly

  2019influential citation
• Methionine Sulfoxide Reductase-B3 Risk Allele Implicated in Alzheimer’s Disease Associates with Increased Odds for Brain Infarcts

  2019cites this paper
• Exploring the Hierarchical Influence of Cognitive Functions for Alzheimer Disease: The Framingham Heart Study

  2019cites this paper
• Genetic Interaction with Plasma Lipids on Alzheimer’s Disease in the Framingham Heart Study

  2018cites this paper
• ELISA-type assays of trace biomarkers using microfluidic methods.

  2017cites this paper
• Practical risk score for 5‐, 10‐, and 20‐year prediction of dementia in elderly persons: Framingham Heart Study

  2017cites this paper
• Cognitive Function in Low-Income and Low-Literacy Settings: Validation of the Tablet-Based Oxford Cognitive Screen in the Health and Aging in Africa: A Longitudinal Study of an INDEPTH Community in South Africa (HAALSI).

  2017cites this paper
• Pathology of Brain Aging

  2017cites this paper
• The Alzheimer's Spectrum: Diagnostic Challenges and Nosology in a Clinically Heterogeneous Disease

  2017cites this paper
• Morphometric Definition of Alzheimer's Disease Stages by Means of The Tomography Dementia Rating Scale (TDR)

  2017cites this paper
• Atrial fibrillation and cognitive decline in the Framingham Heart Study.

  2017cites this paper
• How technology is reshaping cognitive assessment: Lessons from the Framingham Heart Study.

  2017cites this paper
• Cerebral microbleeds and risk of incident dementia: the Framingham Heart Study.

  2017cites this paper
• People with dementia in nursing home research: a methodological review of the definition and identification of the study population

  2016cites this paper
• Orthostatic Hypotension Predicts Cognitive Impairment in the Elderly: Findings from a Cohort Study

  2016cites this paper
• New Genetic Approaches to AD: Lessons from APOE-TOMM40 Phylogenetics

  2016cites this paper
• Social relationships and cognitive decline: a systematic review and meta-analysis of longitudinal cohort studies.

  2016cites this paper
• Cognitive Function in Low-Income and Low-Literacy Settings: Validation of the Tablet-Based Oxford Cognitive Screen in the Health and Aging in Africa A Longitudinal Study of an INDEPTH Community in South Africa (HAALSI)

  2016cites this paper
• Medicare Expenditures of Individuals with Alzheimer's Disease and Related Dementias or Mild Cognitive Impairment Before and After Diagnosis

  2016cites this paper
• A genetics-based biomarker risk algorithm for predicting risk of Alzheimer's disease

  2016cites this paper
• Neuropsychologic assessment.

  2016cites this paper
• Incidence of Dementia over Three Decades in the Framingham Heart Study.

  2016cites this paper
• Two-stage screening for early dementia in primary care

  2016cites this paper
• Effects of emotionally charged auditory stimulation on gait performance in the elderly: a preliminary study.

  2015cites this paper
• 1. Curriculum Vitae

  2015cites this paper
• Novel detection platform for Alzheimer's amyloid-beta using magnetic beads in electrochemical impedance spectroscopy

  2015cites this paper
• Prevalence of dementia in the oldest old: The Monzino 80‐plus population based study

  2015cites this paper
• Neuropsychological and Neuroimaging Characteristics of Amnestic Mild Cognitive Impairment Subtypes: A Selective Overview

  2015cites this paper
• Potential Interactions between the Autonomic Nervous System and Higher Level Functions in Neurological and Neuropsychiatric Conditions

  2015cites this paper
• Magnetic bead droplet immunoassay of oligomer amyloid β for the diagnosis of Alzheimer's disease using micro-pillars to enhance the stability of the oil-water interface.

  2015cites this paper
• Impact of nutrition on cognition and its association with blood and brain Alzheimer disease related biomarkers

  2014cites this paper
• A comparison of emotional decoding abilities in patients with amnestic mild cognitive impairment, very mild and mild Alzheimer's disease.

  2014cites this paper
• Blood biomarkers for Alzheimer’s disease

  2014cites this paper
• Is synaptic loss a unique hallmark of Alzheimer's disease?

  2014cites this paper
• PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS DA MOTRICIDADE

  2014cites this paper
• NÍVEIS DE SOBRECARGA, ANSIEDADE E DEPRESSÃO DE CUIDADORES DE PACIENTES COM DOENÇA DE ALZHEIMER PARTICIPANTES E NÃO PARTICIPANTES DE GRUPOS DE APOIO

  2013cites this paper
• Psychometric Reevaluation of the Spiritual Support Scale

  2013cites this paper
• Alzheimer's Disease Diagnosis and Management

  2013cites this paper
• Is It Time to Rethink How Neuropsychological Tests Are Used to Diagnose Mild Forms of HIV-Associated Neurocognitive Disorders? Impact of False-Positive Rates on Prevalence and Power

  2013cites this paper
• Biomarkers of Alzheimer's Disease Among Mexican Americans

  2013cites this paper
• Executive Function Changes before Memory in Preclinical Alzheimer’s Pathology: A Prospective, Cross-Sectional, Case Control Study

  2013cites this paper
• Screening for Cognitive Impairment in Older Adults: An Evidence Update for the U.S. Preventive Services Task Force

  2013influential citation
• Screening by Telephone in the Alzheimer's Disease Anti-inflammatory Prevention Trial

  2013cites this paper
• Diagnostic accuracy of markers for prodromal Alzheimer's disease in independent clinical series

  2013cites this paper
• Relating Memory to Functional Performance in Normal Aging to Dementia Using Hierarchical Bayesian Cognitive Processing Models

  2013cites this paper
• Should Alzheimer's disease be equated with human brain ageing? A maladaptive interaction between brain evolution and senescence.

  2012cites this paper
• Deterioro cognitivo leve: detección temprana y nuevas perspectivas

  2012cites this paper
• Lack of Correlation of WAIS Digit Span with Clox 1 and the Dementia Rating Scale in MCI

  2012cites this paper
• Identificación y caracterización in silico de la zona de interación entre el péptido beta-amiloide y compuestos derivados del naftaleno In silico identification and characterization of the interaction sites between compounds derivate from naphthalene and beta-amyloid peptide

  2012cites this paper
• Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature

  2012cites this paper
• The tomography dementia rating scale (TDR)—The rating scale of Alzheimer's disease stages

  2012cites this paper
• The Microtubule-Dissociating Tau in Neurological Disorders

  2012cites this paper
• Are clinical diagnoses of Alzheimer's disease and other dementias affected by education and self-reported race?

  2012cites this paper
• Psychometric re-evaluation of the Spiritual Support Scale

  2012cites this paper
• Alzheimer’s Disease: A Clinical Practice-Oriented Review

  2012cites this paper
• [Mild cognitive impairment: early detection and new perspectives].

  2012cites this paper
• Epidemiology of cognitive aging and Alzheimer's disease: contributions of the cache county utah study of memory, health and aging.

  2012cites this paper
• Contributions of the Framingham Heart Study to stroke and dementia epidemiologic research at 60 years.

  2012cites this paper
• Identificación y caracterización in silico de la zona de interación entre el péptido beta-amiloide y compuestos derivados del naftaleno In silico identification and characterization of the interaction sites between compounds derivate from naphthalene and beta-amyloid peptide

  2012cites this paper
• A Scoping Interpretive Review of Literature on Perspectives and Practices of Primary Care Physicians Vis- à-vis Diagnosis and Management of Community Living Older Persons with Dementia

  2012cites this paper
• Implications of a new diagnostic blood test for Alzheimer's disease on future disease management

  2011cites this paper
• Dyscirculatory Angiopathy of Alzheimer's Type

  2011cites this paper
• National estimates of the prevalence of Alzheimer's disease in the United States

  2011cites this paper
• Reducing case ascertainment costs in U.S. population studies of Alzheimer's disease, dementia, and cognitive impairment—Part 2

  2011cites this paper
• Metabolomics in Early Alzheimer's Disease: Identification of Altered Plasma Sphingolipidome Using Shotgun Lipidomics

  2011cites this paper